NxStage Initiates 2013 'Call to Action' Campaign with Launch of Hemodialysis At Home: A Better Way For a Better Life

 NxStage Initiates 2013 'Call to Action' Campaign with Launch of Hemodialysis
                   At Home: A Better Way For a Better Life

New project aims to raise awareness about benefits of home hemodialysis (HHD)
and advocate for reimbursement policy changes with CMS

PR Newswire

LAWRENCE, Mass., Feb. 14, 2013

LAWRENCE, Mass., Feb. 14, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq:
NXTM)is reinforcing its efforts with patients, care partners and renal
professionals to increase awareness about the benefits of home hemodialysis
(HHD) and advocate for reimbursement policy changes with the Centers for
Medicare and Medicaid Services (CMS) specifically as it relates to
reimbursement for HHD training.

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )

Today, the Company initiated its 2013 'Call to Action' campaign with the
launch of Hemodialysis at Home: A Better Way For a Better Life. This effort
will support and showcase the strength of dialyzors, care partners,
physicians, nurses, patient advocates, and other renal professionals who
believe patients need to have better access to the improved survival, clinical
benefits and quality of life reported by many patients receiving more frequent
home hemodialysis. The primary near-term goal of the project is to ensure
that these supporters are heard by government officials and that current
Medicare reimbursement for HHD training is fixed so that more patients have
access to this therapy.

"Patients have a right to be fully informed of all of their treatment options
and to choose whichever therapy is best for them," said Joe Turk, President,
North America at NxStage Medical, Inc. "Hemodialysis at Home is aimed at
stepping up our call to action campaign, increasing awareness, and showcasing
the strength of support for HHD among dialyzors, care partners and the renal
care community. The site is geared to attracting those who seek action and
providing opportunities to engage at whatever level possible to change
policies that limit patient access to this life-changing therapy."

More frequent and at home treatments made possible with home hemodialysis can
allow people with kidney disease the freedom and flexibility to reclaim their
lives. In fact, in a survey,more than 90% of nephrologists said they would
choose a home dialysis therapy for themselves if informed they needed renal
replacement therapy, with HHD being the preferred option. But surprisingly,
more than 90% of patients undergoing dialysis in the United States are doing
three-times-weekly in-center therapy, a therapy very few physicians would
accept for themselves. 

Supporters of Home Hemodialysis: A Better Way For a Better Life believe
patients need to be better educated about the treatment options that exist and
that Medicare payment policies should not prevent them from doing the
treatment that they – and their doctors – feel is best.

About Hemodialysis at Home: A Better Way For a Better Life: Hemodialysis at
Home: A Better Way For A Better Life brings together dialyzors, care partners,
physicians, nurses, patient advocates, and other renal professionals from
across the country who believe patients need to have better access to and more
awareness of the improved quality of life reported to be made possible by home
dialysis technology. Hemodialysis at Home: A Better Way For A Better Life is
a project of NxStage. For more information, please visit www.HemoAtHome.org.

About NxStage Medical Inc.
NxStage is a medical device company, headquartered in Lawrence, MA, USA, which
develops, manufactures, and markets innovative systems for the treatment of
end-stage renal disease (ESRD), and acute kidney failure. The System One home
hemodialysis device developed by NxStage is the only FDA approved portable
hemodialysis machine cleared for home use. For more information on NxStage, or
NxStage products, visit, http://www.nxstage.com.

Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. All statements contained in
this release that are not clearly historical in nature are forward-looking,
and the words "anticipate," "believe," "expect," "estimate," "plan," and
similar expressions are generally intended to identify forward-looking
statements. Actual results may differ materially from those indicated by these
forward-looking statements as a result of various important factors including
those that are discussed in NxStage's filings with the Securities and Exchange
Commission, including the Quarterly Report on Form 10-Q for the quarter ended
September 30, 2012. NxStage is under no obligation to (and expressly disclaims
any such obligation to) update or alter its forward-looking statements,
whether as a result of new information, future events or otherwise.



SOURCE NxStage Medical, Inc.

Website: http://www.nxstage.com
Contact: Kristen Sheppard, +1-978-332-5923, ksheppard@nxstage.com